Hepatitis B vaccine: four decades on

M Mironova, MG Ghany - Vaccines, 2024 - mdpi.com
Hepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC)
globally. Vaccination is the most effective method for prevention of hepatitis B and its …

[HTML][HTML] Impact of point-of-care testing on diagnosis, treatment, and surveillance of vaccine-preventable viral infections

K Lakshmanan, BM Liu - Diagnostics, 2025 - mdpi.com
With the advent of a variety of vaccines against viral infections, there are multiple viruses that
can be prevented via vaccination. However, breakthrough infections or uncovered strains …

Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategies

DM Nair, LK Vajravelu, J Thulukanam, V Paneerselvam… - Virus Genes, 2024 - Springer
Hepatitis B virus (HBV) infection remains a significant global health challenge, with chronic
HBV leading to severe liver diseases, including cirrhosis and hepatocellular carcinoma …

Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia

GCY Lui, GLH Wong, HC Yang, WH Sheng… - HIV …, 2023 - Wiley Online Library
Background The prevalence of HIV and hepatitis B virus (HBV) co‐infection is higher in Asia
than in Europe and North America and varies significantly between different regions within …

[HTML][HTML] Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized …

R Salpini, L Piermatteo, G Torre, S D'Anna… - International Journal of …, 2024 - Elsevier
Abstract Objectives: Here we investigate Hepatitis D virus (HDV)-prevalence in Italy and its
fluctuations over time and we provide an extensive characterization of HDV-infected …

[HTML][HTML] Hybrid large hepatitis B surface protein composed of two viral genotypes C and D induces strongly cross-neutralizing antibodies

T Sanada, Y Oda, C Ohashi, K Isotani, Y Goh… - Vaccine, 2023 - Elsevier
Hepatitis B virus (HBV) vaccination is known to effectively decrease the risk of HBV infection.
However, several issues need to be addressed in order to develop an improved HBV …

[HTML][HTML] Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure

Y Qiu, Q Tang, XQ Liu, YL Xue… - World Journal of …, 2025 - pmc.ncbi.nlm.nih.gov
Hepatitis B virus (HBV) infection is a global health concern. The current sequential
endpoints for the treatment of HBV infection include viral suppression, hepatitis B e antigen …

Molecular epidemiology and genetic characterization of hepatitis B virus in two major provinces of Pakistan

I Almas, S Tariq, I Amin, M Shahid, M Idrees, S Afzal - Archives of Virology, 2024 - Springer
Hepatitis B virus (HBV) infection is a major public health issue and is responsible for
considerable morbidity and mortality globally. In Pakistan, the prevalence of chronic HBV …

[HTML][HTML] Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy

AS Damiani, V Holzmayer, C Galli, M De Nuzzo… - Viruses, 2023 - mdpi.com
Despite good vaccine coverage and careful blood donor selection policies, hepatitis B virus
(HBV) is still the most frequent viral infection among blood donors (BDs) in Italy, mostly in the …

[PDF][PDF] Contemporary Strategies for Managing and Controlling Viral Outbreaks: An Overview

M Ejaz, MA Syed, R Faryal, S Jamil - researchgate.net
Viruses are notorious for causing a significant array of infectious diseases, rendering them a
prominent contributor to global morbidity and mortality rates. Throughout history, various …